Effects of the soluble guanylyl cyclase activator, YC-1, on vascular tone, cyclic GMP levels and phosphodiesterase activity-Reference-Cited by-同舟云学术

Effects of the soluble guanylyl cyclase activator, YC-1, on vascular tone, cyclic GMP levels and phosphodiesterase activity

Published:1999-05 Issue:1 Volume:127 Page:195-203
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:

Author:

Galle Jan,Zabel Ulrike,Hübner Ulrich,Hatzelmann Armin,Wagner Birgit,Wanner Christoph,Schmidt Harald H H W

Publisher

Wiley

Subject

Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1038/sj.bjp.0702495/fullpdf

Reference29 articles.

1. Nitric oxide activates guanylate cyclase and increases guanosine 3′,5′-monophosphate levels in various tissue preparations;ARNOLD;Proc. Natl. Acad. Sci. U.S.A.,1977

2. An improved assay or cyclic 3′,5′-nucleotide phosphodiesterase with QAE sephadex A-25;BAUER;Naunyn-Schmiedeberg's Arch. Pharmaracol.,1980

3. Oxidative chemistry of peroxynitrite;BECKMAN;Meth. Enzymol.,1994

4. Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry;BECKMAN;Biol Chem. Hoppe-Seyler,1994

5. Effects of sodium nitroprusside and other smooth muscle relaxants on cyclic GMP formation in smooth muscle and platelets;BÖHME;Adv. Cyclic Nucleotide Res.,1978

Cited by 170 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeted therapy for non‐small‐cell lung cancer: New insights into regulated cell death combined with immunotherapy;Immunological Reviews;2023-09-08

2. Involvement of HIF1 stabilization and VEGF signaling modulated by Grx‐1 in murine model of bronchopulmonary dysplasia;Cell Biology International;2023-01-14

3. Development of vericiguat: The first soluble guanylate cyclase (sGC) stimulator launched for heart failure with reduced ejection fraction (HFrEF);Biomedicine & Pharmacotherapy;2022-05

4. Inhibition of autophagy by YC-1 promotes gefitinib induced apoptosis by targeting FOXO1 in gefitinib-resistant NSCLC cells;European Journal of Pharmacology;2021-10

5. Blood–Brain Barrier Permeable and NO-Releasing Multifunctional Nanoparticles for Alzheimer’s Disease Treatment: Targeting NO/cGMP/CREB Signaling Pathways;Journal of Medicinal Chemistry;2021-09-13